Genetically-determined thiopurine S-methyltransferase (TPMT) deficiency as a cause of 6-mercaptopurine intolerance in a pediatric ALL patient;Genetycznie uwarunkowany niedobór S-metylotransferazy tiopuryny (TPMT) przyczyna̧ nietolerancji 6-merkaptopuryny u dziecka z ostra̧ białaczka̧ limfoblastyczna̧

Acta Haematologica Polonica

Volumn 39, Issue 3, 2008, Pages 509-514

  Tetera, Edyta ^a   Kurzawski, Mateusz ^b   Peregud Pogorzelski, Jarosław ^a   Urasiński, Tomasz ^a   Droździk, Marek ^b  

^a Klinika Pediatrii

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

6 mercaptopurine (6 MP); Acute lymphoblastic leukemia (ALL); Pharmacogenetics; Thiopurine S methyltransferase (TPMT)

Indexed keywords

MERCAPTOPURINE; METHOTREXATE; THIOPURINE METHYLTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; ENZYME DEFICIENCY; GENETIC ANALYSIS; HUMAN; PANCYTOPENIA;

EID: 56249126371     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Radwańska U. Białaczki u dzieci. Warszawa. Volumed. 1998.
2. Bell BA, Brockway GN, Shuster JJ, et al. A Comparison of Red Blood Cell Thiopurine Metabolites in Children With Acute Lymphoblastic Leukemia Who received Oral Mercaptopurine Twice Daily or Once daily: A Pediatric Oncology Group Study. Pediatr Blood Cancer 2004; 43: 105-109.
3. Ochocka M, Matysiak M. Ostre białaczki u dzieci. Medipress Pediatria. 1996; 2: 16-21.
4. Matysiak M. Hematologia w praktyce pediatrycznej. Warszawa: PZWL; 2002.
5. Silverman LB, Declerck L, Gelber RD, Kimball Dalton V, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Lipton JM, Cohen HJ, Sallan SE. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 2000; 14: 2247-2256.
6. Madeja G. Chemioterapia onkologiczna dorosłych i dzieci. Warszawa: PZWL; 1999.
7. Cheok MH, Evans WE. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat Rev Cancer 2006; 6: 117-129.
8. Krynetski EY, Evans WE. Pharmacogenetics as a molecular basis for individualised drug therapy: the thiopurine S-methyltransferase paradigm. Pharm Res 1999; 16: 342-349.
9. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651-662.
10. McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus - implication for clinical pharmacogenomics. Pharmacogenomics 2002; 3: 89-98.
11. Krynetski EY, Schuetz JD, Galpin AJ, Pui CH, Relling MV, Evans WE. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci USA 1995; 92: 949-953.
12. Kurzawski M, Gawronska-Szklarz B, Drozdzik M. Frequency distribution of thiopurine S-methyltransferase alleles in a Polish population. Ther Drug Monit 2004; 26: 541-545.
13. Relling MV, Hancock ML, Riviera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 1999; 91: 2001-2008.
14. Evans WE, Hon YY, Bomgaars L, Coutre S, et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol. 2001; 19: 2293-2301.
15. Fakhoury M, Andreu-Gallien J, Mahr A, Medard Y, Azougagh S, Vilmer E, Jacqz-Aigrain E. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia? J Clin Pharm Ther. 2007; 32: 633-639.
16. Bosch TM. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Methods Mol Biol. 2008; 448: 63-76.
17. Kurzawski M, Dziewanowski K, Gawronska-Szklarz B, Domanski L, Drozdzik M. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Ther Drug Monit. 2005; 27: 435-441.
18. Chrzanowska M, Kurzawski M, Drozdzik M, Mazik M, Oko A, Czekalski S. Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients. Pharmacol Rep. 2006; 58: 973-978.